Tronox Holdings plc
NYSE:TROXChemicals
-$0.12 today
- Market cap
- $237.96M
- Beta
- 0.74
- P/E (TTM)
- -2.6
- EPS (TTM)
- -$2.91
- Dividend yield
- 2.68%
Volume 19.13M
Average 3.05M
TROX Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Tronox Holdings plcNYSE: TROX
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $86M a year earlier. Trailing-twelve-month research & development was $0. Over 3 fiscal years it compounded at +7.7% a year.
Context
- Research & development amounted to 0.5% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 15M USD
- Year-over-year change
- +7.1%
- 4-year CAGR
- +3.6%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 15M | +7.1% |
| FY2024 | 2024-12-31 | 14M | +16.7% |
| FY2023 | 2023-12-31 | 12M | +0.0% |
| FY2022 | 2022-12-31 | 12M | -7.7% |
| FY2021 | 2021-12-31 | 13M | — |
Research & Development vs competitors
How TROX compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -100.0% is the 3rd highest of 5, against a peer median of -51.1%.
- Research & development amounts to 0.0% of revenue for TROX, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $22.8M USD | -2.1% | +7.9% | 1.2% | |
| LTM Mar 2026 | $10.63M USD | +195.4% | -36.2% | 6.1% | |
| LTM Mar 2026 | $0 USD | -100.0% | +7.7% | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | CA$0 CAD | -100.0% | — | 0.0% | |
| LTM Mar 2026 | $0 USD | -100.0% | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | CA$0 CAD | — | — | — | |
| Peer median (excluding TROX) | — | -51.1% | -14.1% | 0.0% | |
Competitors are the stored peer set for TROX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 3.57B | 3.45B | 2.85B | 3.07B | 2.89B |
| Cost of Revenue | 2.68B | 2.62B | 2.39B | 2.56B | 2.66B |
| Gross Profit | 895M | 832M | 462M | 515M | 229M |
| Gross Margin | 25.1% | 24.1% | 16.2% | 16.8% | 7.9% |
| Research & Development | 13M | 12M | 12M | 14M | 15M |
| Selling, General & Admin | 318M | 289M | 276M | 251M | 244M |
| Operating Expenses | 318M | 374M | 276M | 296M | 259M |
| Depreciation & Amortization | 309M | 281M | 275M | 285M | 323M |
| EBITDA | 840M | 714M | 473M | 525M | 54M |
| EBITDA Margin | 23.5% | 20.7% | 16.6% | 17.1% | 1.9% |
| Operating Income | 577M | 458M | 186M | 219M | (30M) |
| Operating Margin | 16.2% | 13.3% | 6.5% | 7.1% | -1.0% |
| Interest Income | 7M | 9M | 18M | 10M | 6M |
| Interest Expense | 157M | 125M | 158M | 167M | 189M |
| Other Income / Expenses | (203M) | (150M) | (137M) | (146M) | (428M) |
| Income Before Tax | 374M | 308M | 49M | 73M | (458M) |
| Pre-Tax Margin | 10.5% | 8.9% | 1.7% | 2.4% | -15.9% |
| Income Tax Expense | 71M | (192M) | 363M | 127M | 15M |
| Net Income | 286M | 497M | (316M) | (48M) | (470M) |
| Net Margin | 8.0% | 14.4% | -11.1% | -1.6% | -16.3% |
| EPS (Basic) | 1.88 | 3.21 | (2.02) | (0.30) | (2.97) |
| EPS (Diluted) | 1.81 | 3.16 | (2.02) | (0.30) | (2.97) |
| Weighted Avg Shares | 152.06M | 154.87M | 156.4M | 157.82M | 158.48M |
| Weighted Avg Shares (Diluted) | 157.95M | 157.11M | 156.4M | 157.82M | 158.48M |
Tronox Holdings plc
NYSE:TROX
Intrinsic Alpha fair value
Locked
Current Price
$1.49
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.